Physician profile
Martin E Menosky
NPI 1780660886
$1,169.42
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $155.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $346.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $199.39 | 2019-2020 | |
| Allergan, INC. | $147.30 | 2019 | |
| Amgen INC. | $66.11 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.37 | 2019-2020 | |
| Mylan Specialty L.P. | $44.43 | 2019-2020 | |
| Orexo US, INC. | $39.38 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.47 | 2019 | |
| Pfizer INC. | $35.48 | 2020 | |
| Jazz Pharmaceuticals INC. | $26.35 | 2019-2020 | |
| Lilly USA, LLC | $25.65 | 2019 | |
| Antares Pharma, INC. | $24.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.46 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $18.24 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.74 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $12.55 | 2019 | |
| Merck Sharp & Dohme LLC | $12.14 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.13 | 2019 | |
| Glaxosmithkline, LLC. | $11.66 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Menosky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.